
1. biomed res int. 2014;2014:546479. doi: 10.1155/2014/546479. epub 2014 jun 24.

antiangiogenesis therapy endometriosis using pamam gene vector a
noninvasive animal model.

wang n(1), liu b(1), liang l(1), wu y(1), xie h(1), huang j(1), guo x(1), tan
j(1), zhan x(1), liu y(2), wang l(2), ke p(1).

author information: 
(1)department obstetrics gynecology, first affiliated hospital sun 
yat-sen university, 58th zhongshan 2nd road, guangzhou 510080, china.
(2)department pathology, first affiliated hospital sun yat-sen
university, no. 58th zhongshan 2nd road, guangzhou 510080, china.

objective: evaluate characteristics antiangiogenic effects of
endostatin-loaded pamam endometriosis noninvasive animal model.
materials methods: noninvasive animal model established injecting
adenovirus-gfp transfected endometrial stromal glandular epithelial cells
subcutaneously nude mice. endostatin-loaded pamam prepared and
identified transmission electron microscopy. vitro studies, dna
protection cytotoxicity pamam investigated compared with
lipofectamine 2000. vivo study, endostatin-loaded pamam injected 
the noninvasive model evaluated continuously observing fluorescent
lesion, lesion weight, microvessel density vegf immunostaining.
results: compared lipofectamine 2000, pamam hc pamam-es group, mc
pamam-es group lc pamam-es group demonstrated better stromal cells
protective mc pamam-es group cck8 0.617 ± 0.122 24 hr and
0.668 ± 0.143 48 hr lc pamam-es group cck8 0.499 ± 0.103 24 hr
and 0.610 ± 0.080 48 hr stromal cells (p < 0.05) similar cytotoxicity
in glandular epithelial cells vitro. 16 hrs digestion, dna decreased 
slightly protection pamam. endostatin-loaded pamam hd pamam-es
group ld pamam-es group inhibited growth endometriotic lesion in
vivo days 15, 20, 25 30 detected noninvasive observation after
injecting one dose endostatin various medicines endometrial lesion in
each mouse day 10 (p < 0.05) confirmed lesion weight day 30 hd 
pamam-es group 0.0104 ± 0.0077 g ld pamam-es group 0.0140 ±
0.0097 g (p < 0.05). immunohistochemistry results showed endostatin-loaded
pamam reduced microvessel density 3.8 ± 2.4 especially hd pamam-es group
in lesion (p < 0.05).
conclusion: endostatin-loaded pamam inhibits development endometriosis
through antiangiogenic mechanism observed noninvasive
endometriosis model.

doi: 10.1155/2014/546479 
pmcid: pmc4094709
pmid: 25050361  [indexed medline]

